PATENT CLAIM ANALYSIS

Application Number: 15939837
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["514", "294000"]

Abstract:
This invention relates to the use of combinations of stereoisomers of dihydrotetrabenazine for the treatment of movement disorders, such as Tourette's syndrome.

Claim (Index 15):
A method according to  claim 12  wherein the hyperkinetic movement disorder is Huntington's disease.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 90.0
- Lexical Diversity: 1.19048
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15939826', '12555695', '15044655', '15071797', '14030322']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.765034099218346
- 35 USC 102 Novelty (BERT): 0.5824883448293168
- Combined Prediction Score: 0.7467795237794431
- Mean Citation Score: 358.154622
- Max Citation Score: 664.932
- Similarity Product: 349.6830662870408

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test